Latest Content

Mark Schaeffer, OD, FAAO, stated that optometrists should be prepared for even the rarest cases of emergencies and urgencies.

ZEISS partners with Envision to expand evidence-backed VR perimetry, enabling more accessible, gamified home visual field testing for glaucoma monitoring.

The resubmission is considered a Class 1 submission and has a current PDUFA target action date of July 29, 2026.

Raman Bhakhri, OD, FAAO, outlines the biomarkers that optometrists should keep in their wheelhouse when examining patients.

Melody Tavakoli, OD, stated that patient complicance remains one of the biggest challenges for contact lens wearers.

Clinical trial data support the Deseyne contact lens, the first FDA-designated EDOF soft contact lens, as a new daily disposable option for presbyopia.

Lori-Ann Christie, PhD, detailed a poster presentation titled "Comparative Analysis of AREDS2 and AREDS2+B Vitamin Complex in an in vitro Model of Age-Related Macular Degeneration."

Will eye drops be an option in the future for keratoconic patients? Clark Chang, OD, MSA, MSc, FAAO, gave us the run-down of what active research may make possible.

Preservative-free bimatoprost gel now offers once-daily glaucoma and ocular hypertension IOP reduction, aiming to boost comfort, tolerability, and long-term adherence.

Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, details the challenges of managing dry eye in contact lens wearers via accurate diagnosis and thoughtful lens fitting.

Mitch Ibach, OD, FAAO, said that medication optimization is key when taking the interventional approach to glaucoma.

The emerging technology offers a new paradigm for treating a group of eye diseases.

Joe Shovlin, OD, FAAO, outlines the management and treatment of corneal infections in one of his Optometry's Meeting presentations.